RNAmmer Prediction works fine, and 5.8S was intentionally excluded from the prediction, in the paper the authors wrote,
"In eukaryotes, 5S, 5.8S and 28S rRNA exist in the large subunit, and 18S rRNA in the small subunit. The 5.8S is not considered in this work."
-
rRNA identification tools or information PLEASE!
Hi everybody,
I identified in my genome (by blast) 1 contig which is the rRNA genome.
Now, I am searching for tools able to tell me where is exactly all the different part: i mean the 18S/ITS1/5.8S/ITS2/28S...
I tried with RNAmmer Prediction Server.
It give me the 18S and the 28S but not the 5.8S so i guess it is a fake identification...
Or do you have any information about the structure of the rRNA sequence?
So i can find by myself the beginning and the end of each part...
I couldn't found any information !!!!
Thank you very much
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has... -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Leave a comment: